Xiaofei Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaofei Zheng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Amar Sahay
Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.
1 shared publication Bin Liu
Department of Spine Surgery The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China
1 shared publication- Bingbing Qin
Key Laboratory of Mental Health of the Ministry of Education, Guangdong–Hong Kong–Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
1 shared publication - Fan Liu
Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases Department of Cell Biology School of Basic Medical Sciences Southern Medical University Guangzhou China
1 shared publication - Feng Yi
Key Laboratory of Mental Health of the Ministry of Education, Guangdong–Hong Kong–Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
1 shared publication - Fuling Wu
Key Laboratory of Mental Health of the Ministry of Education, Guangdong–Hong Kong–Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
1 shared publication
Latest Publications
- 14 October 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (10) , 2185-2201
Suppressing neural stem cell PLA2G7 restores inhibitory circuit function and improves cognition in aging mice
- 14 October 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (10) , 2185-2201
Suppressing neural stem cell PLA2G7 restores inhibitory circuit function and improves cognition in aging mice
- Open Access
- 11 September 2026
- Published by Wiley in Advanced Science
- p. e77724
Palmitoyl Acyltransferase Zdhhc17 Promotes Functional Recovery After Spinal Cord Injury by Targeting the Nuclear Transport Factors Kpna2 and Ipo9
In adult mammals, poor functional recovery after spinal cord injury (SCI) is largely due to the very limited capacity to reconstruct damaged neural connections together with neuronal loss. Here, we identify the neuroprotective role of Zdhhc17 as a palmitoyl acyltransferase (PAT) following SCI. Neuron‑specific Zdhhc17 overexpression in vitro and in vivo markedly enhances axon regeneration and functional recovery after SCI in a PAT‐activity‐dependent manner. Interactome and palmitoylation analyses in cortical neurons identify the karyopherins Kpna2 and Ipo9 as previously unrecognized Zdhhc17 substrates. SCI markedly reduces Kpna2 and Ipo9 protein levels, whereas Zdhhc17‑mediated palmitoylation stabilizes them by suppressing their ubiquitin‑dependent degradation. Functionally, neuronal overexpression of Kpna2 or Ipo9 mimics the therapeutic effects of Zdhhc17, and co‑expression of Zdhhc17 with Ipo9, but not Kpna2, further augments SCI repair. Using H 2 O 2 ‑induced oxidative stress and glutamate‑induced excitotoxicity models, we further show that Zdhhc17 promotes neuronal survival and activates transcription of intrinsic pro‑regenerative genes after injury. These findings suggest that the Zdhhc17‐Kpna2/Ipo9 axis is a novel pharmacological target for SCI treatment.
- 11 September 2026
- Published by Wiley in Advanced Science
- p. e77724
Open AccessPalmitoyl Acyltransferase Zdhhc17 Promotes Functional Recovery After Spinal Cord Injury by Targeting the Nuclear Transport Factors Kpna2 and Ipo9
In adult mammals, poor functional recovery after spinal cord injury (SCI) is largely due to the very limited capacity to reconstruct damaged neural connections together with neuronal loss. Here, we identify the neuroprotective role of Zdhhc17 as a palmitoyl acyltransferase (PAT) following SCI. Neuron‑specific Zdhhc17 overexpression in vitro and in vivo markedly enhances axon regeneration and functional recovery after SCI in a PAT‐activity‐dependent manner. Interactome and palmitoylation analyses in cortical neurons identify the karyopherins Kpna2 and Ipo9 as previously unrecognized Zdhhc17 substrates. SCI markedly reduces Kpna2 and Ipo9 protein levels, whereas Zdhhc17‑mediated palmitoylation stabilizes them by suppressing their ubiquitin‑dependent degradation. Functionally, neuronal overexpression of Kpna2 or Ipo9 mimics the therapeutic effects of Zdhhc17, and co‑expression of Zdhhc17 with Ipo9, but not Kpna2, further augments SCI repair. Using H 2 O 2 ‑induced oxidative stress and glutamate‑induced excitotoxicity models, we further show that Zdhhc17 promotes neuronal survival and activates transcription of intrinsic pro‑regenerative genes after injury. These findings suggest that the Zdhhc17‐Kpna2/Ipo9 axis is a novel pharmacological target for SCI treatment.